Arena is the biotech stock that bulwnkl posted about a few days ago.
Mostly quoting from bulwnkl, and a bit of my research (accompanied by a dictionary!)
They’re a turnaround, blew a bunch of cash on an obesity drug that no-one bought. They have 3 major drugs in the pipeline, Relinepag which is looking good, but TAM is pretty small. Etrasimod, for treating ulcerative colitis which is what Bulwnkl is excited about, a much bigger TAM.
Olorinab is looking like a next-gen pain killer, which may be anti-inflammatory, looking at treating Crohns pain.
Long-term strategy for Arena “heading to build substantive company over long period”
Bulwnkl has had a pretty stellar record with biotech.
cheers
Greg